News + Filings Transactions Holdings
|
Aquilo Capital Management, LLC
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
ARROWHEAD PHARMACEUTICALS, INC.
| ARWR | COM | 858,474 | -160,000 | 30,613,183,000 | 4,743,943,000 | 16.96 | 0.79 |
Hist
| 06/30/2023 |
Blueprint Medicines Corp
| BPMC | COM | 448,987 | -173,842 | 28,375,978,000 | 354,901,000 | 15.72 | |
Hist
| 06/30/2023 |
iSHARES TRUST
| IWM | Put | 150,000 | 150,000 | 28,090,500,000 | 28,090,500,000 | 15.57 | |
Hist
| 06/30/2023 |
Merus N.V.
| MRUS | COM | 775,109 | -450,000 | 20,408,620,000 | -2,133,386,000 | 11.31 | |
Hist
| 06/30/2023 |
REGENXBIO Inc.
| RGNX | COM | 870,114 | 39,100 | 17,393,579,000 | 1,679,104,000 | 9.64 | 2.00 |
Hist
| 06/30/2023 |
Arvinas, Inc.
| ARVN | Common | 623,941 | -5,000 | 15,486,216,000 | -1,696,452,000 | 8.58 | |
Hist
| 06/30/2023 |
Kymera Therapeutics, Inc.
| KYMR | Common | 651,325 | 50,000 | 14,973,962,000 | -2,843,298,000 | 8.30 | 1.18 |
Hist
| 06/30/2023 |
Silence Therapeutics plc
| SLN | Common | 1,312,233 | 0 | 7,217,282,000 | -918,563,000 | 4.00 | 1.22 |
Hist
| 06/30/2023 |
GENMAB A/S
| GMAB | SPONSORED ADS | 174,648 | -68,200 | 6,638,370,000 | -2,531,570,000 | 3.68 | |
Hist
| 06/30/2023 |
ARGENX SE
| ARGX | SPONSORED ADR | 16,315 | -7,685 | 6,358,445,000 | -2,583,475,000 | 3.52 | |
Hist
| 06/30/2023 |
Olema Pharmaceuticals, Inc.
| OLMA | Common | 250,000 | 250,000 | 2,257,500,000 | 2,257,500,000 | 1.25 | 0.61 |
Hist
| 06/30/2023 |
C4 Therapeutics, Inc.
| CCCC | Common | 760,657 | 760,657 | 2,091,807,000 | 2,091,807,000 | 1.16 | 1.55 |
Hist
| 06/30/2023 |
PIERIS PHARMACEUTICALS, INC.
| PIRS | COM | 3,303,190 | -1,249,686 | 546,678,000 | -3,896,929,000 | 0.30 | 4.03 |
Hist
| 06/30/2023 |
INVESCO QQQ TRUST, SERIES 1
| QQQ | UNIT SER 1 | 0 | -220,000 | 0 | -70,604,600,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
uniQure N.V.
| QURE | Common | 0 | -637,526 | 0 | -12,839,774,000 | 0.00 | 0.00 |
Hist
| 06/30/2023 |
|
|
|
|